Dan Browne

Daniel Browne is a co-founder of the company and has served as our President, Chief Executive Officer and a member of the board of directors since operations commenced in 2002. Prior to joining Revance, Mr. Browne served as President and Chief Executive Officer of Neomend, Inc., a medical technology and biomaterials company; from 2001 to 2003 and from 1997 to 2000 he served as President of Prograft Medical Inc., both companies in the medical technology industry. Previously, Mr. Browne spent more than 16 years in various leadership positions in product development, sales and marketing and business development in the Gore Medical Products Division of W.L. Gore & Associates, Inc., a global technology company, serving as Business Leader in the Medical Products Division as his final role at the company. Mr. Browne holds a B.S. from the University of Hawaii in Cell and Molecular Biology and an M.B.A. from Pepperdine University.